High-Quality CTLA-4 Inhibitor (CAS: 635324-72-0) – Available at Finetech Industry Limited

🔬 Advancing Immunotherapy Research with CTLA-4 Inhibitors 🔬At Finetech Industry Limited, we are committed to providing high-purity research chemicals for cutting-edge scientific advancements. One of our key offerings is CTLA-4 Inhibitor (CAS: 635324-72-0), a promising compound in the field of immunotherapy and oncology research.Product Details🔹 Chemical Name: 2-(4-fluorophenyl)-6-methyl-4-(3-(trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'-d]pyridin-3(6H)-one🔹 CAS Number: 635324-72-0🔹 Purity: High-purity, research-grade🔹 Application: Immuno-oncology, autoimmune disease research, and [...]

Rosmarinic Acid – Premium-Grade Natural Compound for Diverse Applications

Finetech Industry Limited is proud to offer Rosmarinic Acid, a high-purity, naturally sourced phenolic ester compound derived from rosemary (Rosmarinus officinalis), a member of the Lamiaceae family. Also known as Labiatenic Acid, this versatile bioactive ingredient is now available for large-scale production, catering to pharmaceutical, nutraceutical, and cosmetic industries.Key Features & Benefits:Potent Enzyme Inhibition: Exhibits strong inhibitory activity against MAO-A (IC50 = 50.1 μM), MAO-B (IC50 = 184.6 μM), and COMT (IC50 = 26.7 μM), supporting neurological and metabolic heal [...]

2,5-Dichloropyrazine,CAS No :19745-07-4: Synthesis and Diverse Applications

2,5-Dichloropyrazine, CAS:19745-07-4 also known as 2,5-Dichloro-1,4-diazine, is a pharmaceutical intermediate with a molecular formula of C4H2Cl2N2 and a molecular weight of 148.98. This compound holds significant importance in various applications, and its synthesis process involves the chlorination of pyrazine-2-amine to obtain 5-chloropyrazine-2-amine, followed by diazotization to yield 2,5-Dichloropyrazine.Synthesis Process: The synthesis of 5-chloropyrazine-2-amine involves the addition of N-chlorosuccinimide (NCS) to a stirred solution of pyrazine-2-amine in anhydrous dichloromethane un [...]